Abstract
History of ischemic heart disease is a significant risk factor for perioperative cardiac complications, including postoperative myocardial infarction, heart failure, arrhythmia, cardiac arrest, and death. A careful history and physical exam in patients with ischemic heart disease, including prior infarction and/or extent of coronary artery disease (CAD), is crucial prior to surgery to better assess and communicate risk to the patient and surgeon and to suggest management that may mitigate risk perioperatively.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.
Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. J Am Coll Cardiol. 2014. doi:10.1016/j.jacc.2014.07.944.
Holmes DR, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coll Cardiol. 2010;56(17):1357–65.
Vandvik PO, Lincoff AM, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e637S.
Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2013;310(23):2510.
Gwon HC, Hahn JY, Park KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation. 2012;125(3):505–13.
McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27):2795–804.
Burger W, Chemnitius JM, Kneissl GD, et al. Low dose aspirin for secondary cardiovascular prevention: cardiovascular risks and its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med. 2005;257:399–414.
Devereaux PJ, Mrkobrada M, Sessler D. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494–503.
Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. POISE (PeriOperative ISchemic Evaluation) Investigators. Ann Intern Med. 2011;154(8):523.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jackson, M.B. (2015). Ischemic Heart Disease. In: Jackson, M.B., Mookherjee, S., Hamlin, N.P. (eds) The Perioperative Medicine Consult Handbook. Springer, Cham. https://doi.org/10.1007/978-3-319-09366-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-09366-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09365-9
Online ISBN: 978-3-319-09366-6
eBook Packages: MedicineMedicine (R0)